Result of VATS surgery to treat stage III empyema at the Vietnam National Lung hospital

Nguyen Si Khanh, Pham Thi Thanh Dua, Dinh Van Tuan, Nguyen Duc Tuyen, Dang Duy Duc, Dinh Van Luong, Le Ngoc Thanh

Main Article Content

Abstract

Objectives: To describe the clinical and laboratory features of stage III empyema and  to evaluate the effectiveness and safety of  using VATS surgery to treat stage III empyema at the Vietnam National Lung hospital.


Methods: Propective observational study. From 7/2019 to 01/2020 a total of 58 stage III empyema patients diagnosed who were treated at the Department of Thoracic Surgery – NLH were included in this study. Data were analyzed using SPSS software version 22.0Results: Among 58 patients with stage III empyema, 39 were treated by total VATS surgery, 19 by VATS as supported procedures. The mean age was 45±19.5 (17-85) years old. Male/female ratio :3.83. The main clinical symptoms were chest pain (81.0%), shortness of breath (70.7%), cough (60.3%). Average surgical time: 127.2±41.6(60- 250) minutes, draining time: 7.5±3 days, hospitalization time 10.3±3.4 (5-22) day. 96.6% of patients discharged with well conditions, confirmed by lung well-expanded lungs on Xrays, the success rate was 94.8%, and there was no patient death.Conclusion: Diagnosing stage III empyema was mainly based on clinical symptoms, chest HRCT. VATS surgery  is  the safe and effective technique, which helps to reduce surgery time, draining, lying down and reducing pain for patients.

Article Details

References

1. Davies CW, Gleeson FV, Davies RJ. (2003). BTS guidelines for the management of pleural infection. Thorax. 58(2), 18-28.
2. Andrews NC, Parker EF, Shaw RR, et al. (1962). Management of nontuberculous empyema: a statement of the subcommittee on surgery. Am Rev Respir Dis. 85, 935-6.
3. Delorme E (1894). Nouveau traitement des empyèmes chroniques. Gaz Hop. 67, 94-96.
4. Hoàng Đình Cầu và cộng sự. (1984). Khuyến cáo hội thảo bệnh màng phổi. Bệnh lao và Phổi, 15-23.
5. Đinh Văn Lượng (2013), Nghiên cứu chẩn đoán và điều trị phẫu thuật viêm mủ màng phổi người lớn, Đại học Y Hà Nội, Hà Nội.
6. Đinh Văn Lượng, Nguyễn Chi Lăng, Lê Ngọc Thành. (2008). Một số nhận xét về căn nguyên và kết quả mổ bóc vỏ ổ cặn màng phổi qua 42 trường hợp tại khoa Ngoại Bệnh viện Lao và Bệnh phổi Trung ương. Tạp chí Y học thực hành, 7(612-613), 14-16.
7. Đàm Hiếu Bình (2005), Nghiên cứu đặc điểm lâm sàng, cận lâm sàng ở bệnh nhân viêm mủ màng phổi có điều trị ngoại khoa, Đại học Y Hà Nội, Hà Nội.
8. Rafael A. A, Juan D. G, Salomón Z. (2008). Open Thoracotomy and Decortication for Chronic Empyema. Clinics. 63(6), 789-793.
9. Stefano B, Luca V, Sara B, et al. (2017). Uniportal thoracoscopic decortication for pleural empyema and the role of ultrasonographic preoperative staging. Interact CardioVasc Thorac Surg. 24, 560–566.
10. Bagheri R, Haghi S. Z, Dalouee M. N, et al. (2016). Effect of decortication and pleurectomy in chronic empyema patients. Asian Cardiovasc Thorac Ann. 24(3), 245-9.
11. Alan D. L. S. (2012), Topics in Thoracic Surgery, InTech.
12. Weese WC, Shindler ER, Smith IM. (1973). Empyema of the thorax then and now. Arch Intern Med. 13, 516-20.
13. Didier L, Michael G, Edgardo P, et al. (2005). Delayed Referral and Gram Negative Organisms Increase the Conversion Thoracotomy Rate in Patients Undergoing Video-Assisted Thoracoscopic Surgery for Empyema. Ann Thorac Surg. 79, 1851-1856.